RT
GSK icon

Robert Torray’s GSK GSK Stock Holding History

Robert Torray’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-5,200
Closed -$250K – 112
2016
Q4 		$250K Sell
5,200
-1,000
-16% -$49.4K 0.03% 109
2016
Q3 		$334K Hold
6,200
– – 0.04% 79
2016
Q2 		$336K Buy
+6,200
New +$327K 0.03% 78
2014
Q4 		– Sell
-6,200
Closed -$356K – 72
2014
Q3 		$356K Hold
6,200
– – 0.03% 71
2014
Q2 		$414K Buy
+6,200
New +$420K 0.04% 66

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Robert Torray's GSK Position: Q1 2017 in Review

Robert Torray sold out of GSK (GSK) in Q1 2017, closing a stake of 5,200 shares — an estimated $250K sold.

Robert Torray first reported a position in GSK in Q2 2014 and held it in 5 quarters. The position peaked at $414K in Q2 2014. 787 funds tracked by Wall St. Rank hold GSK as of Q1 2017.

  • Robert Torray reported no remaining GSK position as of Q1 2017 after selling out during the quarter.
  • Robert Torray sold 5,200 GSK shares in Q1 2017, an estimated $250K.
  • Robert Torray first reported a position in GSK in Q2 2014 and held it in 5 quarters.
  • Robert Torray's GSK position peaked at $414K in Q2 2014.
  • 787 funds tracked by Wall St. Rank held GSK as of Q1 2017.

Based on Torray Investment Partners's 13F filing for Q1 2017, filed 12 May 2017.